Pacific Biosciences of California Cash Flow-to-Debt Ratio
Pacific Biosciences of California cash flow-to-debt ratio. Pacific Biosciences of California (PACB) has a Cash Flow-to-Debt Ratio of -0.10x as of June 2026, meaning its operating cash flow of $-80.27 Million could theoretically repay 0% of its total liabilities ($785.06 Million) in one year. Check PACB cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Pacific Biosciences of California (2008–2025)
Cash flow-to-debt ratio of Pacific Biosciences of California from 2008 to 2025. Historical debt coverage capacity for Pacific Biosciences of California across 18 annual periods. Check Pacific Biosciences of California total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Pacific Biosciences of California Cash Flow-to-Debt Ratio by Year (2008–2025)
Pacific Biosciences of California cash flow-to-debt ratio by year from 2008 to 2025. Year-by-year debt coverage analysis for Pacific Biosciences of California. For the full cash flow conversion analysis, see PACB operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.14x | $-111.21 Million | $778.73 Million | ▲ +47.8% |
| 2024 | -0.27x | $-206.06 Million | $753.85 Million | ▼ -7.1% |
| 2023 | -0.26x | $-266.55 Million | $1.04 Billion | ▼ -16.7% |
| 2022 | -0.22x | $-263.21 Million | $1.20 Billion | ▼ -139.1% |
| 2021 | -0.09x | $-111.18 Million | $1.22 Billion | ▼ -136.8% |
| 2020 | 0.25x | $19.50 Million | $78.49 Million | ▲ +129.5% |
| 2019 | -0.84x | $-78.31 Million | $93.07 Million | ▲ +28.8% |
| 2018 | -1.18x | $-66.43 Million | $56.21 Million | ▼ -1.5% |
| 2017 | -1.16x | $-67.52 Million | $57.98 Million | ▲ +8.8% |
| 2016 | -1.28x | $-67.93 Million | $53.22 Million | ▼ -53.4% |
| 2015 | -0.83x | $-47.89 Million | $57.57 Million | ▼ -12.5% |
| 2014 | -0.74x | $-51.47 Million | $69.57 Million | ▼ -66.2% |
| 2013 | -0.45x | $-29.83 Million | $67.00 Million | ▲ +88.2% |
| 2012 | -3.78x | $-76.82 Million | $20.30 Million | ▲ +1.3% |
| 2011 | -3.83x | $-102.97 Million | $26.85 Million | ▲ +18.6% |
| 2010 | -4.71x | $-122.00 Million | $25.88 Million | ▼ -1652.4% |
| 2009 | -0.27x | $-74.84 Million | $278.22 Million | ▼ -45.0% |
| 2008 | -0.19x | $-38.30 Million | $206.50 Million | — |